Rights and permissions
About this article
Cite this article
Imatinib mesylate: response in hypereosinophilic syndrome. Inpharma Wkly. 1381, 9 (2003). https://doi.org/10.2165/00128413-200313810-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200313810-00016